Zobrazeno 1 - 10
of 134
pro vyhledávání: '"HBV polymerase"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Viral Hepatitis Journal
Objectives: the aim of the present study was to assess the molecular aspects of HBV strains isolated from chronic hepatitis B (CHB) patients, in the Southeastern region of Turkey. Materials and methods: the study involved a total of 110 patients, 57
Autor:
Ci Song, Juncheng Dai, Xin Xu, Chengxiao Yu, Lijuan Meng, Jibin Liu, Zijun Ge, Ting Tian, Zhibin Hu
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 3086-3093 (2019)
Cancer Medicine
Cancer Medicine
Background Accompanied by HBV infection, HBV mutations gradually occur because HBV polymerase appears proofread deficiencies. In our previous study, we have identified that EnhII/BCP/PC mutations and genotype C of HBV DNA were associated with hepatoc
Publikováno v:
JHEP Reports
JHEP Reports, Vol 3, Iss 4, Pp 100295-(2021)
JHEP Reports, Vol 3, Iss 4, Pp 100295-(2021)
Background & Aims Current standard-of-care suppresses HBV replication, but does not lead to a functional cure. Treatment aiming to cure chronic hepatitis B (CHB) is believed to require the induction of strong cellular immune responses, such as by the
Autor:
Taotao Yan, Naijuan Yao, Jinfeng Liu, Chunhua Hu, Qiang Yu, Li Jin, Yingli He, Yingren Zhao, Jing Wang, Jie Zheng, Yuan Yang, Tianyan Chen
Publikováno v:
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2021 (2021)
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2021 (2021)
Background. HBV-resistant mutants in treatment-naïve patients may lead to antiviral treatment failure. It is not clear if HBV mutants are present in pregnant women and about the influence of the preexisting mutants on the short-term antiviral therap
Autor:
Tianyan Chen, Jinfeng Liu, Qiang Yu, Jing Wang, Li Jin, Yingli He, Chunhua Hu, Jie Zheng, Yingren Zhao, Taotao Yan, Yuan Yang, Naijuan Yao
Background: HBV resistant mutants in treatment-naïve patients may lead to antiviral treatment failure. It’s not clear if HBV resistant mutants present in the pregnant women before the antiviral treatment and the influence of the pre-existing resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a34116826e554be762f234db8f014511
https://doi.org/10.21203/rs.3.rs-44747/v1
https://doi.org/10.21203/rs.3.rs-44747/v1
Publikováno v:
Genes to Cells
Although several nucleo(s)tide analogs are available for treatment of HBV infection, long‐term treatment with these drugs can lead to the emergence of drug‐resistant viruses. Recent HIV‐1 studies suggest that combination therapies using nucleo(
Autor:
Satish B. Bhise
The chapter describes the role of enzyme hepatitis B virus (HBV) polymerase as a target for development of anti-HBV drugs. Introduction gives a brief background about epidemiology of HBV. Structure and genome of HBV are described. The mechanism of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4464b54c13c8090795117b4fbf34e58
https://doi.org/10.1016/b978-0-12-815422-9.00009-7
https://doi.org/10.1016/b978-0-12-815422-9.00009-7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.